| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07575399 Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor… |
Recruitment opened |
| 2026-06-12 | NCT07575399 Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor… |
Trial sites expanded: 0 -> 40 locations |
| 2026-06-11 | NCT07388498 A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and… |
Trial sites expanded: 37 -> 49 locations |
| 2026-06-11 | NCT07388498 A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and… |
date change Completion moved earlier: 2028-07-18 -> 2028-06-18 |
| 2026-06-11 | NCT06252649 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without… |
Trial sites expanded: 286 -> 290 locations |
| 2026-06-11 | NCT06252649 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without… |
date change Primary completion pushed: 2028-01-31 -> 2028-09-25 |
| 2026-06-11 | NCT06252649 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without… |
date change Completion pushed: 2031-08-31 -> 2032-04-25 |
| 2026-06-10 | NCT06700343 Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-10 | NCT06700343 Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) |
Enrollment reduced: 444 -> 152 participants |
| 2026-06-05 | NCT07403721 AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid… |
Trial sites expanded: 10 -> 14 locations |
| 2026-06-05 | NCT07213674 A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With… |
Trial sites expanded: 129 -> 133 locations |
| 2026-06-05 | NCT07226765 Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea… |
Trial sites expanded: 49 -> 53 locations |
| 2026-06-02 | NCT06360354 A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-02 | NCT06360354 A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With… |
Enrollment reduced: 350 -> 120 participants |
| 2026-06-02 | NCT06360354 A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With… |
date change Primary completion moved earlier: 2027-02-26 -> 2026-10-31 |
| 2026-06-02 | NCT06360354 A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With… |
date change Completion moved earlier: 2029-02-25 -> 2026-11-30 |
| 2026-05-30 | NCT07037433 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in… |
Trial sites expanded: 769 -> 772 locations |
| 2026-05-29 | NCT06593522 A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-29 | NCT06593522 A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC… |
Enrollment reduced: 200 -> 61 participants |
| 2026-05-29 | NCT06593522 A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC… |
date change Primary completion moved earlier: 2028-11-29 -> 2026-10-31 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-29 | NCT07614776 A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA®… | Phase 3 | Not Yet Recruiting |
| 2026-05-20 | NCT07598825 A Trial of Inebilizumab in Participants With Autoimmune Hepatitis | Phase 3 | Not Yet Recruiting |
| 2026-05-15 | NCT07590193 A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06072482 | A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis | Antineutrophil Cytoplasmic Antibody-associated Vasculitis | Recruiting |
| NCT06332014 | Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland… | Osteoporosis | Active, Not Recruiting |
| NCT06588153 | A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With… | Glucocorticoid-induced Osteoporosis | Active, Not Recruiting |
| Phase 3 | |||
| NCT03633708 | A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and… | Secondary Hyperparathyroidism | Recruiting |
| NCT03969329 | A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving… | Secondary Hyperparathyroidism | Recruiting |
| NCT07293260 | Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary… | Cardiovascular Disease | Recruiting |
| NCT04804553 | Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis | Active Juvenile Psoriatic Arthritis | Recruiting |
| NCT06747949 | A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) | Sjögren's Syndrome | Recruiting |
| NCT07366086 | Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis… | Osteogenesis Imperfecta | Recruiting |
| NCT06321601 | Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing… | Vasculitis | Recruiting |
| NCT07037459 | Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection… | Heart Failure With Preserved Ejection Fraction | Recruiting |
| NCT07225686 | Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea… | Obesity | Recruiting |
| NCT07037433 | Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in… | Atherosclerotic Cardiovascular Disease | Recruiting |
| NCT05920356 | A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… | Non-Small Cell Lung Cancer (NSCLC) | Recruiting |
| NCT07005128 | A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab… | Small-cell Lung Cancer | Recruiting |
| NCT07136012 | OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a)… | Cardiovascular Disease | Recruiting |
| NCT07213674 | A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With… | Metastatic Castration-resistant Prostate Cancer | Recruiting |
| NCT07226765 | Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea… | Obstructive Sleep Apnea | Recruiting |
| NCT06252649 | Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without… | Metastatic Colorectal Cancer | Recruiting |
| NCT07388498 | A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and… | Uncontrolled Gout | Recruiting |
| NCT07575399 | Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor… | Obesity or Overweight | Recruiting |
| NCT06858878 | Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes… | Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight | Active, Not Recruiting |
| NCT05740566 | Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung… | Small Cell Lung Cancer (SCLC) | Active, Not Recruiting |
| NCT06245408 | A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)… | Sjögren's Syndrome (SS) | Active, Not Recruiting |
| NCT06054555 | A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With… | Melanoma | Active, Not Recruiting |